Back to Article List

FDA and FTC issue warning to companies for marketing dietary supplements with fertility claims


Jun 03, 2021

The Federal Trade Commission has joined the U.S. Food and Drug Administration (FDA) in sending warning letters to five companies that may be making false or unsubstantiated claims that their products can cure, treat, mitigate, or prevent infertility and other reproductive disorders in violation of the FTC Act, and that are unapproved and misbranded.

For further information (in English), click on the FDA and FTC

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox